Sound Income Strategies, LLC Geron Corp Transaction History

Sound Income Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	SELL	$1.67 - $2.94 $554 - $976	-332 Reduced 26.25%	933 $2,000
Q2 2021 Jul 13, 2021	BUY	$1.25 - $1.83 $950 - $1,390	760 Added 150.5%	1,265 $2,000
Q1 2021 Apr 14, 2021	SELL	$1.52 - $2.1 $1,155 - $1,596	-760 Reduced 60.08%	505 $0
Q1 2020 Apr 07, 2020	BUY	$0.89 - $1.49 $830 - $1,390	933 Added 281.02%	1,265 $2,000
Q4 2019 Jan 07, 2020	BUY	$1.27 - $1.54 $421 - $511	332 New	332 $0
Q4 2019 Jan 06, 2020	SELL	$1.27 - $1.54 $10,581 - $12,831	-8,332 Closed	0 $0
Q1 2019 Apr 04, 2019	BUY	$1.01 - $1.83 $8,415 - $15,247	8,332 New	8,332 $14,000

306

465M

1.07M

648K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $971M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Sound Income Strategies, LLC with notifications on news.